SkyView Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
SkyView Investment Advisors's PFE Position: Q1 2026 in Review
SkyView Investment Advisors reduced its Pfizer (PFE) stake by 2.1% in Q1 2026, selling an estimated $25.5K and leaving 44,796 shares worth $1.26M. The position accounts for 0.17% of the portfolio, ranked #81.
SkyView Investment Advisors first reported a position in PFE in Q4 2020 and has held it in 18 quarters since. 2,953 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- SkyView Investment Advisors held 44,796 shares of Pfizer worth $1.26M as of Q1 2026.
- SkyView Investment Advisors sold 956 Pfizer shares in Q1 2026, an estimated $25.5K.
- Pfizer made up 0.17% of SkyView Investment Advisors's portfolio in Q1 2026, its #81 holding.
- SkyView Investment Advisors first reported a position in Pfizer in Q4 2020 and has held it in 18 quarters since.
- 2,953 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on SkyView Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.